Application of Competition Theory to Tumour Growth: Implications for Tumour Biology and Treatment

European Journal of Cancer

Volumn 32, Issue 4, 1996, Pages 722-726

  Gatenby, R A ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Mathematical model; Tumour growth; Tumour host interaction

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CELL DIVISION; HUMAN; NEOPLASM; PATHOLOGY; CANCER THERAPY; MATHEMATICAL MODEL; PRIORITY JOURNAL; TUMOR GROWTH;

CELL DIVISION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 0030124081     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00658-3     Document Type: Article

References (49)

1. Cho KR, Vogelstein B. Genetic alterations in the adenoma-carcinonoma sequence. Cancer 1992, 70, 1727-1731.
2. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989, 49, 3713-3721.
3. Bishop JM. The molecular genetics of cancer. Leukemia 1988, 2, 199-208.
4. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 1982, 21, 998-1003.
5. Gatenby RA. Population ecology issues in tumor growth. Cancer Res 1991, 51, 2542-2547.
6. Laird AK. Dynamics of tumor growth: comparison of growth rates and extrapolation of growth curves to one cell. Br J Cancer 1965, 19, 278-291.
7. Garland H, Coulson W, Wollin E. The rate of growth and apparent duration of untreated primary bronchial carcinoma. Cancer (Phil.) 1963, 16, 699-707.
8. Shymko RM. Cellular and geometric control of tissue growth and mitotic instability. J Theor Biol 1976, 63, 355-374.
9. Sherratt JA, Nowak MA. Oncogenes, anti-oncogenes and the immune response to cancer: a mathematical model. Proc R Soc Lond B 1992, 248, 261-271.
10. Michelson S, Leith JT. Interlocking triads of growth control in tumors. Bull Math Biol 1995, 57, 345-366.
11. Wheldon TE. Mitotic autoregulation of normal and abnormal cells: alternative mechanisms for the derangement of growth control. J Theor Biol 1975, 53, 421-433.
12. Albrecht F, Gatzke H, Haddad A, Wax N. The dynamics of two interacting populations. J Math Anal Applic 1974, 46, 658-670.
13. Goel NS, Maitra SC, Montroll EW. On the Volterra and other nonlinear models of interacting populations. Rev Modern Phys 1971, 43, 231-276.
14. Summers D, Wu ZY. Disturbed nonlinear multispecies models in ecology. Math Biosci 1991, 104, 185-201.
15. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 1994, 54, 1178-1189.
16. Marks F, Furstenberger G. The conversion stage of skin carcinogenesis. Carcinogenesis 1990, 11, 2085-2092.
17. Lowry S. Molecular basis for hormone-related cancer. Lancet 1993, 41, 1630.
18. Dickson RB, Johnson MD, Bano M. Growth factors in breast cancer: mitogenesis to transformation. J Steroid Biochem Molec Biol 1992, 43, 69-78.
19. Geller J. Basis for hormonal management of advanced prostate cancer. Cancer 1993, 171, 1039-45.
20. Shroder FH. Endocrine therapy for prostate cancer: recent developments and current status. Br J Urol 1993, 71, 633-640.
21. Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrine Rev 1992, 133, 17.
22. Sainsbury JRC, Niciholson S, Angus B, et al. Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer 1988, 58, 458-460.
23. Berger MS, Greenfield C, Gullick WJ, et al. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 1987, 56, 533-537.
24. Veale D, Kerr N, Gibson GJ, Harris AL. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 1989, 49, 1313-1317.
25. Cullen KJ, Lippman ME, Chow D, et al. Insulin-like growth factor-II induces phenotypic changes associated with malignant progression. Molecular Endocrin 1992, 6, 91-100.
26. Chackal-Roy M, Niemeyer C, Moore M, Zetter BR. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 1989, 84, 43-50.
27. Millar-Book W, Orr FW, Singh G. In vitro effects of bone- and platelet-derived transforming growth factor-B on the growth of Walker 256 carcinosarcoma cells. Clin Expl Metastatis 1990, 8, 503-510.
28. Kostenuik PJ, Singh G, Suyama KL, Orr FW. A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis 1992, 10, 403-410.
29. Cullen KM, Smith HS, Mill S, Rosen W, Lippman ME. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 1991, 51, 4978-4985.
30. Miller FR, McEachern D, Miller BE. Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. Cancer Res 1989, 49, 6091-6097.
31. Hodges GM, Hicks RM, Spacey GD. Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder. Cancer Res 1977, 37, 3720-3730.
32. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerebel RS. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 1991, 88, 6028-6032.
33. Kabalin JN, Peehl DM, Stamey TA. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 1989, 14, 251-263.
34. Camps JL, Chang SM, Hsu TC, et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990, 87, 75-79.
35. Clarke R, Dickson RB, Brunner N. The process of malignant progression in human breast cancer. Ann Oncol 1990, 1, 401-407.
36. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339, 58-61.
37. Folkman J. The role of angiogenesis in tumor growth. Cancer Biol 1992, 3, 65-71.
38. Folkman J, Watson K, Ingber D, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. In Harris CC, et al, eds. Multistage Carcinogenesis. CRC Press, Bolaration, 1991, 339-347.
39. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992, 84, 1875-1887.
40. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastatis - correlation in invasive breast carcinoma. N Engl J Med 1991, 324, 1-8.
41. Rastineajad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56, 345-355.
42. Lippman ME, Dickson RB, Bates S. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 1986, 7, 59.
43. Warburg O. The metabolism of tumours (translated into English by F. Dickens), London, Constable, 1930.
44. Hatanaka M, Huebner RJ, Gilden RV. Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. J Natl Cancer Inst 1969, 43, 1091-1096.
45. Kalckar HM, Kijomoto US, Hakomori S. Carbohydrate catabolism and the enhancement of uptake of galactose in hamster cells transformed by polyoma virus. Proc Natl Acad Sci USA 1973, 70, 839-843.
46. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987, 235, 1492.
47. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990, 348, 699-704.
48. Ossowski L. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 1992, 52, 6754-6760.
49. r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992, 52, 1336-1341.